Advocacy Committee Review of Prescription to OTC Switch for Norgestrel

OnTuesday, May 9th, NASPAG was one of 37 different organizations and/or individuals to speak at the Open Public Hearing session of the joint meeting of the Nonprescription Drugs Advisory Committee and the Obstetrics, Reproductive and Urologic Drugs Advisory Committee of the FDA. The Advisory Committee was assembled to review the application from HRA Pharma for a "prescription-to-OTC" switch for Norgestrel 0.075mg (Opill) as a progestin-only oral contraceptive. Speakers included several major medical societies, reproductive justice and advocacy organizations, and many youth who boldly shared their personal stories! Out of the 37 speakers, 35 spoke in strong support of the proposal. 

Bright Girl Skincare - Exclusive Discount for NASPAG Members

Hello NASPAG members:

Joint Statement on Adolescents and Young Adults following Dobbs v. Jackson Women’s Health Organization

The Supreme Court’s ruling in Dobbs v. Jackson is an egregious attack on bodily autonomy, removing a pregnant person’s right to autonomous decision making over the most personal and most consequential of life decisions. While this is devastating for all persons, adolescents and young adults will suffer greatly from this decision. This ruling reversed nearly 50 years of legal precedent, issued a direct assault on reproductive justice and the public’s health, and curtailed the status of pregnant persons as free and equal citizens (as noted in the dissenting opinion). We are collectively opposed to this violation of human rights, which will be especially harmful to vulnerable and marginalized populations including adolescents and young adults. We object to any restrictions placed on the reproductive rights of adolescents and young adults. Access to safe abortion is a basic part of comprehensive reproductive health care. This ruling contradicts the broad medical and scientific consensus that abortion is a fundamental component of healthcare, abortion is safe, and abortion is a human right.

The Future of Abortion Care

NASPAG will continue to support and advocate for comprehensive sexual and reproductive care for all.  We continue to oppose legislation that interferes in the patient - health care provider relationship.  Please see this ACOG Message for a summary of strategies that supports access to and provision of abortion care.

Read more

Talking points - COVID-19 Vaccine and Reproductive Health

With ongoing COVID-19 surges, the need for vaccine uptake among adolescent and young adults is critical to safety and decreasing transmission. Although there is no preferred vaccine formulation, the Pfizer-BioNtech vaccine is the sole formulation that received full FDA approval. Twelve to seventeen-year olds are currently only eligible to receive the Pfizer-BioNtech vaccine. The FDA has also recently approved the Pfizer-BioNtech vaccine for those 5-11 years of age, and it is anticipated that other countries will approve the same in the coming weeks around the world.

Read More

Our 2024 Annual Clinical Research Meeting will be held on April 4 - 6 in Orlando

Thank you for a tremendous ACRM 2023!

1941 - First textbook of Pediatric Gynecology in the US by Goodrich Shauffler